Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NCO 700

Known as: NCO-700 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The specific thiol protease inhibitor, NCO-700, which is related to L-trans-epoxysuccinylpeptides, inhibited oxidant production… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2000
2000
Purpose: The overall purpose of this study was to determine the potential efficacy of epoxide-containing piperazines as a new… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 6
Is this relevant?
1999
1999
Little is known as yet about the role of apoptosis in pancreatic damage. This study evaluated the effects of supraphysiologic… Expand
Is this relevant?
1998
1998
The participation of oxidative mechanisms in major histocompatibility complex (MHC) class II-restricted antigen presentation was… Expand
Is this relevant?
1998
1998
Activation of trypsinogen is thought to trigger the autodigestive process in acute pancreatitis. The lysosomal enzyme cathepsin B… Expand
Is this relevant?
1997
1997
This study evaluated the action of menadione on cell proliferation and integrity of the rat pancreatic acinar cell line, AR4-2J… Expand
Is this relevant?
1997
1997
It is well known that activation of proteases in the lysosomes and cytosol is one of the mechanisms of ischemic injury. It might… Expand
  • figure 1
  • table 1
  • figure 2
  • table 6
Is this relevant?
1985
1985
During myocardial ischemia in dogs effects of NCO-700, a protease inhibitor on myocardial pH, were investigated. Ischemia was… Expand
Is this relevant?
1985
1985
NCO-700 is a newly synthesized inhibitor of both cathepsin B and calcium-activated neutral protease. We examined whether NCO-700… Expand
Is this relevant?
1982
1982
Calcium-activated neutral protease (CANP) might be involved in the irreversible degradation of myocardial proteins in the… Expand
Is this relevant?